Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Qiuzi Dai, Cunlong Zhang, Zigao Yuan, Qinsheng Sun & Yuyang Jiang. (2020) Current discovery strategies for hepatocellular carcinoma therapeutics. Expert Opinion on Drug Discovery 15:2, pages 243-258.
Read now
Read now
Wen Wen Xu, Bin Li & Annie L M Cheung. (2015) The potential of targeted antiangiogenesis therapies in the treatment of esophageal cancer. Gastrointestinal Cancer: Targets and Therapy 5, pages 79-88.
Read now
Read now
Articles from other publishers (22)
Anne-Rose W. Schut, Anne L.M. Vriends, Andrea Sacchetti, Milea J.M. Timbergen, Benjamin A. Alman, Mushriq Al-Jazrawe, Dirk J. Grünhagen, Cornelis Verhoef, Stefan Sleijfer & Erik A.C. Wiemer. (2022) In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition. European Journal of Surgical Oncology 48:7, pages 1527-1535.
Crossref
Crossref
Kuo-Liang Wei, Guan-Lun Gao, Yu-Ting Chou, Chih-Yi Lin, Shan-Chun Chen, Yi-Ling Chen, Hui Qin Choi, Chi-Chia Cheng & Jyan-Gwo Joseph Su. (2022) Sorafenib is an antagonist of the aryl hydrocarbon receptor. Toxicology 470, pages 153118.
Crossref
Crossref
Simran Kaur, Nupur Angrish, Kajal Gupta, Anil K. Tyagi & Garima Khare. (2021) Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment. Infection, Genetics and Evolution 87, pages 104662.
Crossref
Crossref
Xiaomin Ma, Yumin Qiu, Lihui Zhu, Yunxue Zhao, Yueke Lin, Dapeng Ma, Zhenzhi Qin, Caiyu Sun, Xuecheng Shen, Tao Li & Lihui Han. (2019) NOD1 inhibits proliferation and enhances response to chemotherapy via suppressing SRC-MAPK pathway in hepatocellular carcinoma. Journal of Molecular Medicine 98:2, pages 221-232.
Crossref
Crossref
Laura Mazilu, Dana Stanculeanu, Andreea Gheorghe, Adrian-Paul Suceveanu, Irinel Parepa, Felix Voinea, Doina Catrinoiu & Andra-Iulia Suceveanu. 2019. Metformin [Working Title]. Metformin [Working Title].
Jun Deng, Mei Peng, Zhiren Wang, Sichun Zhou, Di Xiao, Jiating Deng, Xue Yang, Jingyuan Peng & Xiaoping Yang. (2019) Novel application of metformin combined with targeted drugs on anticancer treatment. Cancer Science 110:1, pages 23-30.
Crossref
Crossref
Zhiyong Ma, Xia Liu, Huifen Dong, Dong Xia, Lixia Wang, Yu Chen & Yong Xiong. (2018) Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice. Parasitology Research 117:9, pages 2831-2839.
Crossref
Crossref
Galina Khemlina, Sadakatsu Ikeda & Razelle Kurzrock. (2017) The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Molecular Cancer 16:1.
Crossref
Crossref
Nicoletta Potenza, Nicola Mosca, Silvia Zappavigna, Filomena Castiello, Marta Panella, Carmela Ferri, Daniela Vanacore, Antonio Giordano, Paola Stiuso, Michele Caraglia & Aniello Russo. (2017) MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells. Journal of Cellular Physiology 232:7, pages 1907-1913.
Crossref
Crossref
Sufang Yang & Guohua Liu. (2017) Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma. Oncology Letters 13:3, pages 1041-1047.
Crossref
Crossref
Ivan Haralampiev, Holger A. Scheidt, Tobias Abel, Madlen Luckner, Andreas Herrmann, Daniel Huster & Peter Müller. (2016) The interaction of sorafenib and regorafenib with membranes is modulated by their lipid composition. Biochimica et Biophysica Acta (BBA) - Biomembranes 1858:11, pages 2871-2881.
Crossref
Crossref
Nestor Prieto-Domínguez, Raquel Ordóñez, Anna Fernández, Andres García-Palomo, Jordi Muntané, Javier González-Gallego & José L. Mauriz. (2016) Modulation of Autophagy by Sorafenib: Effects on Treatment Response. Frontiers in Pharmacology 7.
Crossref
Crossref
Constantinos Alifieris & Dimitrios T. Trafalis. (2015) Glioblastoma multiforme: Pathogenesis and treatment. Pharmacology & Therapeutics 152, pages 63-82.
Crossref
Crossref
Li Xu, Hengjun Gao, Junting Huang, Haoyuan Wang, Zhongguo Zhou, Yaojun Zhang, Shaohua Li & Minshan Chen. (2015) Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib. Journal of Gastroenterology and Hepatology 30:6, pages 1032-1039.
Crossref
Crossref
Djoeke de Wit, Henk-Jan Guchelaar, Jan den Hartigh, Hans Gelderblom & Nielka P. van Erp. (2015) Individualized dosing of tyrosine kinase inhibitors: are we there yet?. Drug Discovery Today 20:1, pages 18-36.
Crossref
Crossref
Carmen Fucile, Simona Marenco, Marco Bazzica, Maria Laura Zuccoli, Francesca Lantieri, Luigi Robbiano, Valeria Marini, Paola Di Gion, Giulia Pieri, Paola Stura, Antonietta Martelli, Vincenzo Savarino, Francesca Mattioli & Antonino Picciotto. (2014) Measurement of sorafenib plasma concentration by high-performance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? A pilot study. Medical Oncology 32:1.
Crossref
Crossref
A. Kornberg. (2014) Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatology 2014, pages 1-25.
Crossref
Crossref
Chieh-Lin Teng, Wen-Li Hwang, Yi-Ju Chen, Kuang-Hsi Chang & Shao-Bin Cheng. (2012) Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study. World Journal of Surgical Oncology 10:1.
Crossref
Crossref
Anastasios J. Karayiannakis, Stylianos Kakolyris, Alexandra Giatromanolaki, Nikos Courcoutsakis, Helen Bolanaki, Leonidas Chelis, Efthimios Sivridis & Constantinos Simopoulos. (2011) Hepatoid Adenocarcinoma of the Gallbladder. Journal of Gastrointestinal Cancer 43:S1, pages 139-144.
Crossref
Crossref
HIROKI UEDA, HIROKO FUKUCHI & CHIGUSA TANAKA. (2012) Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review). Oncology Letters 3:2, pages 259-263.
Crossref
Crossref
Yafei Zhang, Bicheng Zhang, Anran Zhang, Yong Zhao, Jie Zhao, Jian Liu, Jianfei Gao, Dianchun Fang & Zhiguo Rao. (2012) Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells. Clinics 67:9, pages 1093-1099.
Crossref
Crossref
Adrian Lupescu, Nazneen Shaik, Kashif Jilani, Christine Zelenak, Elisabeth Lang, Venkanna Pasham, Mohanad Zbidah, Ansgar Plate, Michael Bitzer, Michael Föller, Syed M. Qadri & Florian Lang. (2012)
Enhanced Erythrocyte Membrane Exposure of Phosphatidylserine Following Sorafenib Treatment: An
in vivo
and
in vitro
Study
. Cellular Physiology and Biochemistry 30:4, pages 876-888.
Crossref
Crossref